LWM
GSK icon

Lyons Wealth Management’s GSK GSK Stock Holding History

Lyons Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,182
Closed -$213K – 72
2014
Q2 		$213K Buy
+3,182
New +$215K 0.19% 63
2013
Q4 		– Sell
-3,182
Closed -$200K – 74
2013
Q3 		$200K Buy
+3,182
New +$205K 0.18% 58

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lyons Wealth Management's GSK Position: Q3 2014 in Review

Lyons Wealth Management sold out of GSK (GSK) in Q3 2014, closing a stake of 3,182 shares — an estimated $213K sold.

Lyons Wealth Management first reported a position in GSK in Q3 2013 and held it in 2 quarters. The position peaked at $213K in Q2 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Lyons Wealth Management reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Lyons Wealth Management sold 3,182 GSK shares in Q3 2014, an estimated $213K.
  • Lyons Wealth Management first reported a position in GSK in Q3 2013 and held it in 2 quarters.
  • Lyons Wealth Management's GSK position peaked at $213K in Q2 2014.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Lyons Wealth Management's 13F filing for Q3 2014, filed 14 Nov 2014.